Keywords
SARS-CoV-2 Infection
Bronchoalveolar Lavage
How to Cite
Abstract
Alveolar pulmonary proteinosis is the accumulation of surfactant in the alveolar spaces and terminal bronchioles, evidenced by the dysfunction of the alveolar macrophages, which causes respiratory failure. It is not very prevalent in people of all races, sexes and ages. The worldwide prevalence is up to 7 cases per million inhabitants, at the moment without local epidemiology. This is the case of a young woman with a history of alveolar proteinosis who presented exacerbation secondary to a confirmed Sars-Cov 2 infection, so she required lung lavage. She was readmitted for repeated spontaneous pneumothoraces and is awaiting lung transplantation. This is one of the few published cases of coincidence of both pathologies and in the current post-pandemic context, it is expected that these cases will be presented more frequently, so it is important to determine guidelines for proper diagnosis and management.
References
Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. Lancet. 2018;6(7):554-565.
McCarthy C, Avetisyan R, Carey BC, Chalk C, Trapnell BC. Prevalence and healthcare burden of pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2018;13(1):129-133.
Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, et al. Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan. Am J Respir Crit Care Med. 2008;177(7):752-62.
Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16.
Bula C, Santiago E, Martínez B, Reyes M, Pabón R. Proteinosis alveolar. Rev Colomb Neumol. 2017;29(1):55–62.
Boily-Daoust C, Fortin M, Dumas A, Bussières J. Granulocyte Macrophage Colony-Stimulating Factor and whole lung lavage for pulmonary alveolar proteinosis: A synergistic effect? Can J Respir Crit Care Sleep Med. 2022;6(2):73–5.
Jouneau S, Ménard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology. 2020;25(8):816–26.
Algarin H, Mendoza DA, Molano D, Claro J. Proteinosis alveolar pulmonar: diagnóstico y manejo en unidad de cuidado intensivo. Reporte de caso. Acta Colomb de Cuid Intensivo. 2017;17(1):76–80.
De Wever W, Meersschaert J, Coolen J, Verbeken E, Verschakelen JA. The crazy-paving pattern: a radiological-pathological correlation. Insights Imaging. 2011;2(2):117–132.
Pilavaki M, Smias C, Palladas P. Proteinosis alveolar pulmonar secundaria en un paciente inmunodeprimido con infección por citomegalovirus. Arch de bronconeumol. 2009;45(4):204–205.
Campo I, Meloni F, Gahlemann M, Sauter W, Ittrich C, Schoelch C, et al. An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis. Sci Rep. 2022;12(1).
Kelly A, McCarthy C. Pulmonary Alveolar Proteinosis Syndrome. Semin Respir Crit Care Med. 2020; 41 (2): 288-298.
Shrestha D, Dhooria S, Munirathinam GK, Sehgal IS, Prasad KT, Ram B, et al. How We Do It: Whole Lung Lavage. Sarcoidosis Vasc Diffuse Lung Dis. 2022; 39(2).
Adel W, Omar A, Eldegwy M. Management of pulmonary alveolar proteinosis using whole lung lavage, recent update. Egypt J Hosp Med. 2022;88(1):3058-3062.
Carrington JM, Hershberger DM. Pulmonary Alveolar Proteinosis. StatPearls [Internet]. 2022. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK482308/.
Akasaka K, Tanaka T, Kitamura N, Ohkouchi S, Tazawa R, Takada T, et al. Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study. BMC Pulm Med. 2015;15(88).
Iftikhar H, Nair GB, Kumar A. Update on diagnosis and treatment of adult pulmonary alveolar proteinosis. Ther Clin Risk Manag. 2021;17(1):701–710.
Long B, Carius BM, Chavez S, Liang SY, Brady WJ, Koyfman A, et al. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. Am J Emerg Med. 2022;54:46–57.
Powers KJ, Avadhanula V, Patel PR, Sarkar PK, Piedra P, Zarrin-Khameh, N. Whole lung lavage: Treating pulmonary alveolar proteinosis at the time of COVID pandemic. Respir Med Case Rep. 2020;39.
Papiris SA, Campo I, Mariani F, Kallieri M, Kolilekas L, Papaioannou AI, et al. COVID-19 in patients with Pulmonary Alveolar Proteinosis: a European multicenter study. ERJ Open Res. 2023;9(1):00199-2022.
Tiperneni R, Padappayil RP, Khalid F, Chandini Arjun A, Al-Alwan A, Li B. Pulmonary alveolar proteinosis in the time of COVID-19: The radiologic mimicker. Chest. 2022;162(4):A1804.
Sisman M, Karapolat S, Topaloglu O, Akdogan A, Turkyilmaz A. A case of pulmonary alveolar proteinosis misdiagnosed as COVID-19 pneumonia. Cir Cir. 2022;90(3):402-405.
Colares P, Silva N, Kairalla RA, Baldi BG. COVID-19 and pulmonary alveolar proteinosis: an unusual combination. J Bras Pneumol. 2023;49(1):e20220330.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Médicas UIS